Fresenius Medical Care AG (XTER:FME) 3-Year FCF Growth Rate : -15.10% (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Fresenius Medical Care AG 3-Year FCF Growth Rate?

Fresenius Medical Care AG's Free Cash Flow per Share for the three months ended in Dec. 2023 was €1.60.

During the past 12 months, Fresenius Medical Care AG's average Free Cash Flow per Share Growth Rate was 34.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -15.10% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 8.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Fresenius Medical Care AG was 39.50% per year. The lowest was -15.10% per year. And the median was 13.30% per year.

Competitive Comparison of Fresenius Medical Care AG's 3-Year FCF Growth Rate

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresenius Medical Care AG's 3-Year FCF Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's 3-Year FCF Growth Rate falls into.

Fresenius Medical Care AG 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

Fresenius Medical Care AG (XTER:FME) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.

Fresenius Medical Care AG 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresenius Medical Care AG (XTER:FME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (XTER:FME) » Definitions » 3-Year FCF Growth Rate

Comparable Companies

Traded in Other Exchanges

FMCQF:USA FMS:USA FME:Italy FMEd:UK 0H9X:UK FMSC34:Brazil FME:Austria

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.freseniusmedicalcare.com

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.

Executives

Dr. Katarzyna Mazur-hofsäß	Board of Directors
Harry De Wit	Board of Directors
Dr. Olaf Schermeier	Board of Directors

Fresenius Medical Care AG (XTER:FME) Headlines

No Headlines